投稿

ラベル(migraine)が付いた投稿を表示しています

韓国頭痛学会 日韓合同シンポジウム 2024年12月1日

イメージ
 

頭痛講演 2023年1月19日、26日

イメージ
 

Kikui S, Chen Y, Ikeda K, Hasebe M, Asao K, Takeshima T.  BMJ Open. 2022;12(11):e065787.

イメージ
    Kikui S, Chen Y, Ikeda K, Hasebe M, Asao K, Takeshima T.  Comorbidities in patients with migraine in Japan: a cross-sectional study using data from National Health and Wellness Survey.  BMJ Open. 2022;12(11):e065787. https://www.ncbi.nlm.nih.gov/pubmed/36450434 https://bmjopen.bmj.com/content/bmjopen/12/11/e065787.full.pdf 2022/12/01

Japan Migraine Academy 2022

イメージ
    Aimovigが上市されて1年を記念して海外のTopExpertである、Goadsby先生とTepper先生にレクチャーいただきました。 ホットトピックスのセッションはわが国のExpert、今井昇先生、松森保彦先生、五十嵐久佳先生

 Sakai F, Hirata K, Igarashi H, Takeshima T, Nakayama T, Sano H, et al.  J Headache Pain. 2022;23(1):70.

イメージ
 Sakai F, Hirata K, Igarashi H, Takeshima T, Nakayama T, Sano H, et al.  A study to investigate the prevalence of headache disorders and migraine among people registered in a health insurance association in Japan.  J Headache Pain. 2022;23(1):70. https://www.ncbi.nlm.nih.gov/pubmed/35733104 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9219245/pdf/10194_2022_Article_1439.pdf 2022/06/23  

Bibliography 2021 Takao Takeshima (2021年論文業績)

 英文原著 1) Takeshima T , Sakai F, Hirata K, Imai N, Matsumori Y, Yoshida R, Peng C, Cheng S, Mikol DD.  Erenumab treatment for migraine prevention in Japanese patients: Efficacy and safety results from a Phase 3, randomized, double-blind, placebo-controlled study. Headache 2021;61(6): 927-935. https://www.ncbi.nlm.nih.gov/pubmed/34153117 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8361926/pdf/HEAD-61-927.pdf   2)  Hirata K, Sakai F, Takeshima T , Imai N, Matsumori Y, Yoshida R, Numachi Y, Peng C, Mikol DD, Cheng S. Efficacy and safety of erenumab in Japanese migraine patients with prior preventive treatment failure or concomitant preventive treatment: subgroup analyses of a phase 3, randomized trial. J Headache Pain. 2021;22(1): 110. https://www.ncbi.nlm.nih.gov/pubmed/34537006 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449906/pdf/10194_2021_Article_1313.pdf 3)  Hirata K, Ueda K, Komori M, Zagar AJ, Selzler KJ, Nelson AM, Han Y, Jaffe DH, Matsumori Y, Takeshim...

Danno D, Wolf J, Ishizaki K, Kikui S, Hirata K, Takeshima T. BMC Neurol. 2022;22(1):89.

イメージ
      Danno D, Wolf J, Ishizaki K, Kikui S, Hirata K, Takeshima T.  Cranial autonomic symptoms in migraine are related to central sensitization: a prospective study of 164 migraine patients at a tertiary headache center.  BMC Neurol. 2022;22(1):89. https://www.ncbi.nlm.nih.gov/pubmed/35287610 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919542/pdf/12883_2022_Article_2610.pdf 2022/03/16